Pharmaceutisch Weekblad

, Volume 2, Issue 1, pp 589–590 | Cite as

Meting van geneesmiddelengebruik

  • J. S. Meulenhoff


  1. Agid, Y., P. Pollak, A. M. Bonnet, J. L. Signoret enF. Lehrmitte (1979) Bromocriptine associated with a peripheral dopamine blocking agent in the treatment of Parkinson's disease.Lancet 1, 570–572.Google Scholar
  2. Bateman, D. N., enD. S. Davies (1979) Pharmacokinetics of metoclopramide.Lancet 1, 166.Google Scholar
  3. Baumann, H. W., R. A. L. Sturdevant enR. W. Maccallum (1979) L-dopa inhibits metoclopramide stimulation of the lower esophageal sphincter in man.Dig. Dis. Science 24, 289–295.Google Scholar
  4. Bogaerts. M., M. Braams enC. Martens (1979) Domperidon in the prevention of L-dopa induced nausea.J. Postgraduate Med. 55 (Suppl. 1)51.Google Scholar
  5. Brouwers, J. R. B. J., J. Assies, W. M. Wiersinga, G. Huizing enG. N. Tytgat (1980) Plasma Prolactin levels after acute and subchronic oral administration of domperidone and of metoclopramide. A cross over study in healthy volunteers.Clin. Endocrinol. (aangenomen voor publikatie).Google Scholar

Copyright information

© Bohn, Scheltema & Holkema 1980

Authors and Affiliations

  • J. S. Meulenhoff

There are no affiliations available

Personalised recommendations